Konanda Pharma Partners

Konanda Pharma Partners is a specialty pharmaceutical company focused on the acquisition, management, and commercialization of established pharmaceutical brands. The company specializes in identifying legacy or non-core assets from global pharmaceutical firms and transitioning them into a dedicated environment where they receive renewed strategic focus. By optimizing supply chains and maintaining high-quality standards, Konanda ensures that essential medicines remain accessible to patients worldwide. Their current portfolio is highlighted by the acquisition of the respiratory medication Accolate (zafirlukast) from AstraZeneca. The leadership team consists of seasoned industry executives with a proven track record in the specialty pharma and value-added medicines sectors.